Aethlon Medical Inc (AEMD) - Total Liabilities
Based on the latest financial reports, Aethlon Medical Inc (AEMD) has total liabilities worth $1.34 Billion USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Aethlon Medical Inc (AEMD) equity growth momentum to track the company's year-over-year net asset growth rate.
Aethlon Medical Inc - Total Liabilities Trend (1997–2025)
This chart illustrates how Aethlon Medical Inc's total liabilities have evolved over time, based on quarterly financial data. See Aethlon Medical Inc (AEMD) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Aethlon Medical Inc Competitors by Total Liabilities
The table below lists competitors of Aethlon Medical Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
INFINITII AI INC.
F:Y31
|
Germany | €2.30 Million |
|
Greencastle Resources Ltd.
V:VGN
|
Canada | CA$73.75K |
|
BlockMint Technologies Inc
V:BKMT
|
Canada | CA$45.76K |
|
Regent Pacific Properties Inc
V:RPP
|
Canada | CA$19.99 Million |
|
Logistics Development Group PLC
LSE:LDG
|
UK | GBX375.00K |
|
BLOCKMATE VENTURES INC.
F:8MH
|
Germany | €7.30 Million |
|
DELPHI WORLD MONEY LIMITED
NSE:DELPHIFX
|
India | Rs5.86 Billion |
Liability Composition Analysis (1997–2025)
This chart breaks down Aethlon Medical Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Aethlon Medical Inc worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Aethlon Medical Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Aethlon Medical Inc (1997–2025)
The table below shows the annual total liabilities of Aethlon Medical Inc from 1997 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | $2.24 Million | -9.83% |
| 2024-03-31 | $2.48 Million | +1.43% |
| 2023-03-31 | $2.44 Million | +0.75% |
| 2022-03-31 | $2.43 Million | +76.45% |
| 2021-03-31 | $1.38 Million | +23.87% |
| 2020-03-31 | $1.11 Million | -39.13% |
| 2019-03-31 | $1.82 Million | +38.27% |
| 2018-03-31 | $1.32 Million | +16.64% |
| 2017-03-31 | $1.13 Million | +7.26% |
| 2016-03-31 | $1.05 Million | +44.59% |
| 2015-03-31 | $729.21K | -95.56% |
| 2014-03-31 | $16.43 Million | +70.37% |
| 2013-03-31 | $9.64 Million | -4.87% |
| 2012-03-31 | $10.13 Million | +54.89% |
| 2011-03-31 | $6.54 Million | +29.61% |
| 2010-03-31 | $5.05 Million | +21.74% |
| 2009-03-31 | $4.15 Million | +8.83% |
| 2008-03-31 | $3.81 Million | -50.55% |
| 2007-03-31 | $7.71 Million | +176.24% |
| 2006-03-31 | $2.79 Million | -17.17% |
| 2005-03-31 | $3.37 Million | -14.47% |
| 2004-03-31 | $3.94 Million | -2.17% |
| 2003-03-31 | $4.02 Million | +26.90% |
| 2002-03-31 | $3.17 Million | -15.44% |
| 2001-03-31 | $3.75 Million | +84.45% |
| 2000-03-31 | $2.03 Million | +158.47% |
| 1999-03-31 | $786.57K | +39645.78% |
| 1998-03-31 | $1.98K | +465.43% |
| 1997-03-31 | $350.00 | -- |
About Aethlon Medical Inc
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Di… Read more